Innovate UK logo

Global Business Innovation Programme

Explore and exploit the collaboration, growth and innovation opportunities that exist in a specific business market.
AMR sweden GBIP

Global Business Innovation Programme

Focusing on Antimicrobial Resistance (AMR) Switzerland

Innovate UK is inviting ambitious and innovative UK companies to participate in the Global Business Innovation Programme (GBIP).

Application closing date: 12/12/2023

Applications now closed

Watch the online Applicant Briefing Event to find out more about this GBIP.

The programme consists of a preparation phase, a five-day innovation visit focused on Antimicrobial Resistance (AMR), a post-visit exploitation workshop and follow up support from an Innovate UK Business Growth Innovation and Growth Specialist.

The programme is designed to help your business maximise the opportunities identified, including developing innovation projects with partners in the territory.

Innovate UK is committed to improving the diversity of who we support. As such, we welcome applications from under-represented groups.

Why Switzerland?

Switzerland has recognised the importance of AMR and the Swiss Antibiotic Resistance Strategy (StAR) was created in close cooperation between the Federal Office of Public Health, the Federal Food Safety and Veterinary Office, the Federal Office for Agriculture, the Federal Office for the Environment, and the Swiss Conference of Cantonal Ministers of Public Health. StAR recognises the need to prevent the development of new resistant organisms and limit their transmission and spread and that this is an international issue. The strategy’s implementation which began in early 2016 determined eight strategic fields of activity and objectives and also importantly recognises the cooperation between the different areas is extremely important to ensure each area’s integrity, i.e., a One Health approach. As a consequence, there is a significant AMR Ecosystem within Switzerland.

Currently, the One Health Action Plan 2024-27 of the Strategy Antibiotic Resistance Switzerland (StAR) is being developed with various partners and stakeholders from research, politics, and industry. This is coincidental with the UK developing its next National Plan. Thus, there are clear parallels between the UK and Switzerland.

The 8th AMR Conference will be held in Basel, Switzerland focusing on Novel Antimicrobials & AMR Diagnostics. The innovation visit will include access to both days of the conference providing opportunities to hear from world-leading AMR experts, as well as 1-to-1 matchmaking meetings to find new collaborators and partners and to grow your business.

Focus Areas

This initiative is particularly relevant for businesses with a focus of Diagnostics, Therapeutics, Stewardship, Infection control, Vets and Vaccines at the core of their value proposition.


  • Explore opportunities for AMR collaboration in Switzerland
  • Visit major tech clusters and international AMR Conference to gain a better understanding of the challenges and opportunities of doing business in these markets
  • Meet key AMR players
  • Find potential innovation collaborators and partners, and develop your network in the UK and globally
  • Improve your company value proposition to international partners and investors

Key Dates

Applications Open: Monday 6 November 2023
Briefing Workshop: Monday 20 November 2023
Applications Close: Tuesday 12 December 2023
Notification to Successful Applicants: Wednesday 20 December 2023
Pre-visit Workshop: Monday 22 & Tuesday 23 January 2024
Innovation Market Visit: Sunday 3 — Friday 8 March 2024.
Exploitation Workshop: Mid to late April 2024 – Date TBA.


Innovation visit - example itinerary (subject to change)
The cost
How to apply
For more information

Useful information

Related links
Leading the visit
Bita Najafi

Bita joined Innovate UK EDGE in 2021 and is supporting SMEs in the South East region in achieving their business objectives and to help them grow.

Rocky Moore

Rocky is an Innovation & Growth Specialist and has been supporting SME growth for many years.

Dr. Phil Packer

Phil is the Innovation Lead for AMR and Vaccines at Innovate UK, developing and delivering funding calls, supporting workshops and strategy.

Dr. Maarten van Dongen

Maarten is an AMR expert and founder of AMR Insights BV. He is a Molecular and Medical Microbiologist by origin.

Take part in a Global Business Innovation Programme and benefit from sector and market expertise.

Applications now closed